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Much of the vast amount of research that has been done on leukemogenesis in 
the mouse has centered on the AKR strain. 
In this inbred strain, which Furth developed by selecting for high incidence of leuke- 
mia, the majority of mice die of leukemia within 1 yr (1). These leukemias are virtually 
all of the T-lymphocyte type and originate in the thymus or from cells derived from the 
thymus. The incidence of leukemia is greatly reduced by thymectomy in early life (2). It 
is from this strain that Gross (3) first isolated murine leukemia virus (MuLV), 1  and AKR 
mice are now known to carry at least two chromosomal loci, demonstrated by Rowe and 
his colleagues to be integrated MuLV genomes which independently entail the spontane- 
ous production of MuLV in high titer from around the time of birth (4). Other loci that 
predispose to leukemia are (a) Fv-1, which governs infective dissemination of MuLV (5) 
and (b) H-2-1inked genes of which one may control proliferation of MuLV and MuLV- 
infected cells via immune responsiveness (6, 7), and another which may concern the pro- 
duction of virions (8). 
Leukemia  in  AKR  mice  is  obviously  related  to  age,  the  incidence  rising 
sharply between  6  and  12  mo after birth.  This has not been accounted  for in 
terms of MuLV production, which reaches a  plateau in very early life and does 
not greatly increase until  the onset of overt leukemia  (9).  Much the same has 
been reported of quantitative measurements of viral gs antigens (10). Nonethe- 
less, there is ample evidence of morphological thymic changes, such as cortical 
atrophy, which precede the development of leukemia (11). 
In our work with MuLV-associated antigens  (12), we have been impressed by 
their  apparently  far  greater  expression  on  leukemia  cells  as  compared  with 
MuLV-infected but nontransformed lymphoid cells.  We assumed to begin with 
that this 'amplification' was synchronous with the leukemogenic transformation 
itself.  But this  we find is not the  case,  as is shown in the following report on 
MuLV-associated and other surface antigens expressed on thymocytes of AKR 
mice at various ages. 
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Materials  and Methods 
Mice.  From our colonies or from The Jackson Laboratory, Bar Harbor, Maine. For description 
of congenic strains see Table I. 
Antisera, Reference Cells, and Complement Source.  See Table II. 
Cytotoxic Test (16).  Equal volumes of cells (5 x  10e/ml), a serial dilution of antiserum and an 
appropriate dilution of complement were mixed and incubated at 37°C for 45 rain. After addition of 
0.16% freshly prepared trypan blue, a  count of stained and unstained cells was made. 
Quantitative Absorption Test (22, and Table II).  After absorbing aliquots of diluted antiserum 
with a  range of counted numbers of cells,  the residual activity of the serum was tested in the 
standard cytotoxic test. 
Absorption Index.  (a) Glx and Gross cell surface antigen (GCSA): the number of cells (B6-GI× + 
thymocytes from 2-too-old donors for Gjx assays and pooled spleen cells from 2 to 3-too-old AKR 
mice for GCSA assays) required to reduce the cytotoxicity of reference antiserum to 40% lysis of 
the standard test cell divided by the number of AKR thymocytes or leukemia cells required to 
reduce the cytotoxicity of the antiserum to the same level. (b) H-2, Thy-1, and Ly-2: the number of 
cells from 2-too-old donors (10 x  10  e B6-H-2  k thymocytes for H-2% 3 x  108 A-Thy-l.1 thymecytes for 
Thy-1.1 assays, and 3 ×  106 B6-Ly-2.1 thymocytes for Ly-2.1 assays) divided by the number of AKR 
thymocytes or leukemia cells which give the same percent lysis of the standard test cell. 
Membrane Immunofluorescence Test for gp70 and p30 Antigens  (23).  A mixture of 1:40 diluted 
antiserum (50 ftl) and cell suspension (25 ~l, 2 x  107/ml) was incubated at 4°C for 30 min. The cells 
were washed twice and resuspended in 50/~l fluoresceinated antigoat or rabbit immunoglobulin 
depending on the source  of the antiserum.  After incubation for 30 rain at 4°C,  the cells were 
rewashed twice and examined with a  Leitz Orthoplan microscope equipped with an Osram HBO 
200 mercury lamp, and BC 38 exciter, KP 490 interference, and K  530 harrier filters. 
The two antisera used in these tests were: goat anti-gp69/71 MuLV-Rauscher (24), provided by 
Doctors M.  Strand and J.  T.  August, Albert Einstein College of Medicine, and rabbit anti-p30 
MuLV-Rauscher (25), provided by Doctors E. Fleissner and W. D. Hardy, Jr., of this Institute. 
Bovine Serum Albumin (BSA) Gradient Separation (26).  Approximately l0  s AKR thymocytes 
were suspended in 1 ml of 35% BSA (Path-o-cyte 5, Pentex, Miles Laboratories Inc., Kankakee, 
Ill.) in a  5-ml Beckman cellulose-nitrate centrifuge tube. On this was layered 1 ml each of 26, 23, 
20, and 10% BSA (diluted in medium  199),  and the tube was then centrifuged at 4°C  at 13,000 
rpm for 30 min in a  Beckman SW 50.1 rotor. The four layers obtained were designated A  (at the 
10-20% interface), B(20-23%), C(23-26%), and D(26-35%). 
Cytograf Analysis.  AKR thymocyte suspensions were  adjusted to  2  x  105 cells per ml and 
examined with a Cytograf Model 6300 (Bio/Physics Systems Inc., New York), coupled with a pulse 
height analyzer (NS Econ Series, Northern Scientific Inc., Wisconsin). 
Results 
Cytotoxic Tests  with  Broadly  Reactive  MuLV Antisera.  Thymocytes from 
AKR mice of various ages were examined in direct cytotoxic tests with (W/Fu x 
BN)F1 anti-W/Fu(C58NT)D serum. This antiserum (which is referred to as anti- 
NTD)  was  produced  by immunization  with  a  MuLV-induced  transplantable 
lymphoma  of W/Fu origin  and  contains  antibodies  to  a  spectrum  of MuLV- 
related  antigens  (15).  Fig.  1 illustrates  cytotoxic tests with thymocytes from 
individual 2 wk to 6-mo-old AKR mice and with thymic leukemia cells. Thymo- 
cytes from young AKR mice show a  low level of cytotoxicity with  anti-NTD 
serum,  whereas  thymic  leukemia  cells  are  strongly  reactive.  Cytotoxic tests 
with thymocytes from individual 6-mo-old mice reveal that anti-NTD reactivity 
falls into two categories,  low sensitivity comparable to young mice and  high 
sensitivity approaching that seen with AKR leukemia cells. 
Characteristics of Thymocytes from Preleukemic Mice.  Before detailed anal- 
ysis of the amplified expression of MuLV antigens  in the thymus of 6-mo-old 
AKR mice, it was essential to exclude the possibility of microscopic leukemia KAWASHIMA,  IKEDA,  STOCKERT,  TAKAHASHI,  AND  OLD 
TABLE  I 
Description  of Congenic Stocks Derived from C57BL/6(B6) and A 
Strains Used in this Study 
195 
Donor strain  of  Name  Different  locus  Reference 
allele 
B6-H-2  k  H-2  AKR  13 
B6-Ly-2.  I  Ly-2  C3H/An  13 
B6-GIx  +  Gv-1, Gv-2  129  14 
A-Thy-1.1  Thy-1 CO")  AKR  13 
TABLE II 
Description  of Serological  Typing Systems for Quantitative Absorption Tests 
Antigenic  Antiserum  Standard test cell  Complement source  Reference 
system  (serum dilution) 
G~x  Rat (W/Fu x BN)F, anti-W/  B6-G~x  +thymocytes  Rabbit  (i:15)  15, 16 
Fu  leukemia  (C58NT)D 
(anti-NTD) (1:600") 
GCSA  B6  antitransplanted  sponta-  EdG2  Guinea pig (1:2)  17 
neous  AKR leukemia K36  leukemia cells 
(1:30") 
H-2  k  (B6  ×  BALB/c)F~ anti-C3H  B6-H-2  k  Guinea pig (1:4)  18 
ascites  sarcoma  BP8  lymphocytes 
(1:900") 
Thy-l.1  (B6  x  A)F~ anti-A-Thy-l.1  A-Thy-l.1  Rabbit  (1:15)  19, 20 
thymocytes (1:120")  thymocytes 
Thy-l.2  (A-Thy-l.1  × AKR-H-2b)F~  B6 thymocytes  Rabbit  (1:15) 
anti-A strain  spontaneous 
leukemia ASL1 (1:500") 
19, 20 
Ly-2.1  B6-H-2  k anti-CE thymocytes  B6-Ly-2.1  Rabbit  (1:15)  20, 21 
{  1:100"  )  thymocytes 
* Dilution of  antiserum used in the quantitative absorption tests as determined by preliminary assays. 
cell infiltration  and replacement.  As a  rule,  thymic leukemia cells are clearly 
larger  than  normal  thymocytes,  and  the  experienced  microscopist  has  little 
difficulty in distinguishing them. Such inspection revealed no significant differ- 
ence in size between thymocytes from 2-mo and 6-mo-old AKR mice. Examina- 
tion of cell size distribution by Cytograf analysis substantiated this. In addition, 
separation of cells by BSA gradient centrifugation showed essentially the same 
distribution pattern for thymocytes from 2-mo and 6-mo-old mice. The predomi- 
nant  cell type of the  thymus,  the  small  cortical  thymocyte, is found in the  D 
layer; thymocytes from 6-mo-old AKR mice showing increased anti-NTD sensi- 
tivity were also found in this layer. 
The  critical  test  for  the  presence  of leukemia  cells  is  transplantability  to 
syngeneic  hosts.  5-10  ×  106  leukemia  cells  from  AKR  mice  with  thymoma 
produces evident disease in young AKR recipients within 3 wk; leukemia did not 
result (observation period 100 days) from the inoculation of 50-100  ×  106 thymo- 196  CELL  SURFACE  ANTIGENS  OF  PRELEUKEMIC  AKR  THYMOCYTES 
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FIG,  1.  Cytotoxic tests with the broadly reactive MuLV antiserum  (W/Fu x  BN)F~ anti- 
W/Fu leukemia (C58 NT)D; comparative sensitivity ofAKR thymocytes from donors aged 2 
wk to 6 too. Complement source; guinea pig serum diluted 114. Each line represents a titra- 
tion with cells from a  single donor. 
cytes from individual 6-mo-old AKR mice with amplified MuLV antigen expres- 
sion. 
Age-Related Changes in the Quantity of Individual MuL V-Related Antigens 
Expressed on AKR Thymocytes.  As anti-NTD is a polyvalent antiserum capa- 
ble of detecting  a range of viral and cellular antigens  related to MuLV,  we set 
about to determine whether the increased reactivity of preleukemic thymocytes 
to anti-NTD is due to increased coordinate expression of all MuLV antigens or to 
selected determinants  only. For this reason, the amount of four MuLV-related 
antigens,  G~×, GCSA,  gp70,  and p30,  on AKR thymocytes  was determined. KAWASHIMA,  IKEDA,  8TOCKERT, TAKAHASHI,  AND  OLD  197 
G  ix Antigen 
G~x was first detected on normal thymocytes of the low leukemia incidence strain 129 
in cytotoxic tests with anti-NTD (16). In typing thymocytes of mice from various strains, 
two C~x  phenotypes could be distinguished,  C~x- and  C~x  +.  The C~x  + group could be 
further subdivided on the basis  of quantitative expression of Glx into G~x  I,  G]x  2,  G1x  3 
strains. AKR belongs to the Gix  2  strains; thymocytes of (:}ix  2  mice express about two-thirds 
the quantity of Gtx compared to Glx  3 mice (129, B6-GIx  +, etc.). Gix- cells can be converted 
to  GI× + by  MuLV  infection  in  mice  as  well  as  rats,  suggesting  coding  of G~x  by 
viral genes rather than host genes (16). It was originally thought that Glx was a nonvirion 
antigen specified by MuLV, since it occurred on thymocytes of strains such as 129 that 
showed no evidence of MuLV infection. We now know that G]x is a type-specific determi- 
nant of the major envelope glycoprotein of MuLV, gp70,  which can be independently 
expressed without concommitant expression of other viral gene products (27, 28). 
Fig.  2  illustrates  individual  quantitative  absorption  tests  for G~x, and  the 
results of all tests are summarized in Fig. 3. Thymocytes from the low leukemic 
B6-G[x  + strain served as control cells (see Table II). AKR thymocytes reach adult 
Gix  2 levels at about 6 wk of age, and this does not change for several months. At 
5-6 too, the majority of AKR mice showed a threefold or greater increase in the 
amount of G[x antigen. Leukemia cells invariably express the highest amount of 
(}ix.  In  contrast  to  AKR  mice,  expression  of G]x  antigens  on  thymocytes of 
individual B6-G]x  + mice remains constant with age. Two other G]x + strains with 
low leukemia incidence, 129 and A, show no age-related change in the level of 
Glx antigen on thymocytes. 
GCSA Antigen 
GCSA is found on the surface of cells replicating MuLV and,  as such,  is a  useful 
marker  for  overt  MuLV  infection  (29). All  mouse  strains  with  a  high  incidence 
of leukemia (AKR, C58, AKR-H-2  b, C3H/Fg, PL) type GCSA+; low incidence strains are 
either GCSA- or show levels of the antigen below the level of sensitivity of the GCSA 
typing method (17). Aging is known to influence expression of GCSA; spleens from young 
C3Hf/Bi are GCSA-, but by 6 mo of age they convert to GCSA  ÷ (30). As GCSA typing sera 
failed to react with  the  viral  envelope in  immunomicroscopy, it was  concluded that 
GCSA, although virus specified, was not a structural component of MuLV (31). Further 
work is needed to clarify this question, since GCSA may still be a component of the virus, 
but occupy a position in the intact virion that is inaccessible to antibody. 
Fig. 4 illustrates individual quantitative absorption tests for GCSA, and the 
results of all tests are summarized in Fig.  5.  In young AKR mice, thymocytes 
show far lower levels of GCSA than  spleen cells  (17).  By 6 too, however, the 
quantity  of GCSA  on  AKR  thymocytes is  generally  greatly  increased.  This 
increase  in  GCSA  on 6-mo thymocytes corresponds to the  high  GCSA  levels 
found on AKR leukemic cells. 
gp70 and p30 Antigens 
Eight pelypeptides, including reverse transcriptase,  have been identified in MuLV 
(25, 32). The two structural components most intensively studied are gp70,  the major 
glycoprotein of the viral envelope, and p30, the major core protein. Although it was ex- 
pected that gp70  would be expressed on the cell surface, the demonstration that p30 
determinants could also  be detected on the  surface of cells came  as  a  surprise  (33). 
Whether p30 is an integral part of the membrane or simply adsorbed to the surface is 
currently being studied. 198  CELL  SURFACE  ANTIGENS  OF  PRELEUKEMIC  AKR  THYMOCYTES 
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Fig.  6 summarizes our data on surface gp70 and p30 of AKR thymocytes and 
leukemia cells detected by indirect membrane immunofluorescence tests.  Thy- 
mocytes of AKR mice aged 1-5 mo show virtually no reactivity with anti-gp70 or 
anti-p30.  By 6  mo,  increased  numbers  of p30 + and  gp70 ÷ cells  appear in  the 
thymus,  and there is a  strong tendency for coordinate expression of these two 
antigens in individual mice. Leukemia cells exhibit strong gp70 and p30 reactiv- 
ity.  Immunofluorescence  tests  on  sections  of 6-mo-old  AKR  thymus  localize 
increased gp70 and p30 expression to the thymic cortex. >2.0 
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Age-Related Changes in the Expression of H-2, Thy-1, and Ly-2 Alloantigens 
on AKR Thymocytes 
Thymocytes from adult mice characteristically express little H-2 and much Thy-1 and 
Ly alloantigens.  This  contrasts  with  the  high  H-2/low  Thy-1  and  Ly phenotypes of 
peripheral T lymphocytes. Alloantigens specified by the H-2 locus are found on a variety 
of cell types. Thy-1  and  Ly antigens have a  more restricted tissue distribution,  with 
antigens of the Ly series being found only on cells of T lineage (34). 
Fig.  7-11  summarize  our studies on the expression of H-2, Thy-1,  and Ly-2 
antigens on thymocytes of AKR mice of various ages and on thymic leukemia 
cells.  Direct  cytotoxic tests  and  quantitative  absorption  analysis  reveal  that 
thymocytes from 6-mo-old mice may have two to three times the quantity of H-2 
antigens  expressed  by thymocytes  of younger  mice.  This  high  H-2  level  of 
thymocytes from preleukemic mice parallels the high H-2 phenotype of thymic 
leukemia cells. Age-related changes in Thy-1 antigen follow a reverse pattern. 
Thy-1 expression is highest  on 2-mo-old AKR thymocytes and falls with age. 
Leukemia cells, like 6-mo thymocytes, show a  low Thy-1 phenotype. Although 
not as striking as changes in Thy-1 levels, the quantity of Ly-2 also decreases 
with age. 
Thymocytes from mouse strains with a low incidence of leukemia do not show 
significant age-related changes in the expression of H-2, Thy-1, or Ly-2 antigens 
(Fig. 9-11). In addition to the strains reported in this study, we have examined 
the level of H-2 and Thy-1 antigens on thymocytes from 2 and 6-mo-old mice of a 
variety of other low incidence strains,  including C3H/An, B6, B6-G,x +,  129, A, 
and DBA/2 mice. In no instance did we find thymic changes comparable to those 
observed in AKR mice. 
Discussion 
From the time that Willis enunciated his 'field therapy' of cancer (35), it has 
become increasingly  clear that  cancer is not characteristically  initiated  as an 
abrupt event in which a normal cell acquires autonomy. Foulds coined the term 
'tumor  progression'  in  reference  to  the  sequential  deviations from  normality 
which precede the evolution of frank malignancy in the mouse mammary gland 
(36).  Tumor  progression  is perhaps  most exquisitely illustrated  by endocrine 
tumors of rodents (37). Here the progress to autonomy, defined as transplanta- 
bility to  nonconditioned  hosts,  is  preceded  by stages  described as  'hormone- 
dependent'  and later 'hormone-responsive',  cells in either state being unques- 
tionably  malignant  and  indefinitely  transplantable  in  hormone-conditioned 
hosts;  earlier  still  there  are  well-defined  morphological  changes,  such  as 
adenoma formation which, although 'benign' by all criteria, constitute a step on 
the road to malignancy. Thus, it does not seem possible to ascribe ~malignancy' 
in general to a  single event which can convert a  normal cell into a cancer cell. 
'Premalignant'  lesions are a  characteristic feature of cancer in laboratory ani- 
mals no less than in man. They are more commonly recognized where the tissue 
involved is readily accessible, as in the case of the breast or uterine cervix. The 
investigation  of premalignancy  in leukemia  is feasible in the mouse, because 
the disease commonly starts as a  localized focus in the thymus,  characteristi- 
cally  in  one  lobe  of the  thymus  (38).  Histological  changes  in  the  thymus, 202  CELL  SURFACE  ANTIGENS  OF  PRELEUKEMIC  AKR  THYMOCYTES 
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spanning  the period before frank  malignancy,  (i.e., before any clone of autono- 
mously proliferating transplantable  cells has appeared) have been described in 
detail (11,  38).  Metcalf (11) summarizes  these as cortical thinning  accompanied 
by medullary  enlargement  with structures  resembling  lymphoid follicles. With KAWASHIMA,  IKEDA,  STOCKERT,  TAKAHASHI,  AND  OLD 
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Fro.  9.  Quantitative differences expressed as an absorption index in the amount of H-2  k 
antigen on thymocytes from AKR and B6-H-2  k mice of various ages and on AKR thymic 
leukemia cells.  Each symbol represents results obtained with cells from a  single donor. 
Reference cells for calculating absorption index; B6-H-2  k thymocytes from 2-mo-old donors. 
regard to biochemical changes, Kemp and Duquesnoy (39) have recently re- 
ported that adenylate cyclase levels are elevated in both leukemic as well as 
preleukemic (>6 too) AKR thymus. From the present work, we now see that 
thymocytes also undergo characteristic antigenic changes in their surface phe- 
notype during the preleukemic phase.  By 6 mo of age, expression of several 
MuLV-related antigens (G[×, GCSA, gp70, and p30) on AKR thymocytes  may be 
sharply increased.  2 The pattern of alloantigen representation is also  signifi- 
cantly altered in the preleukemic thymus. Whereas thymocytes from young 
adult mice characteristically show high Thy-1/low H-2 expression, the reverse 
(low Thy-1/high H-2) is found on thymocytes from 6-mo-old AKR mice. Compa- 
rable age-related change in surface phenotypes has not been observed in tests 
with thymocytes  from a number of strains having a low incidence of leukemia. 
There are several possibilities to account for these changes in AKR mice: 
(a)  Replacement  of Thymus  by  Cells  of a  Different  (e.g.,  Non-T)  Lin- 
eage.  This possibility can be excluded. Thymocytes from 2-mo and 6-mo-old 
2 Comparable amplification in MuLV-antigen expression on thymocytes of older mice has now 
been found in another strain having a  high incidence of leukemia, C58. 204  CELL  SURFACE  ANTIGENS  OF  PRELEUKEMIC  AKR  THYMOCYTES 
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FIG.  10.  Quantitative differences expressed as an absorption index in the amount of Thy-1 
antigen on thymocytes of AKR mice of various ages and on AKR thymic leukemia cells. 
Each symbol represents results obtained with cells from a single donor mouse.  Reference 
cells for calculating absorption index; A-Thy-l.1 thymocytes from 2-mo-old donors. As the 
thymus  of 6-too-old A-Thy-l.1  mice is  exceedingly small,  it  was  not  possible  to  obtain 
meaningful determinations of Thy-1.1 levels. For control purposes, B6 mice (Thy-l.2) were 
studied;  thymocytes  from  2  and  6-mo-old  donors  showed  comparable  levels of Thy-l.2 
antigen. 
AKR mice are of similar size and bouyant density, show comparable cortisone 
sensitivity,  and  in  direct  cytotoxic tests  >90%  are  marked  by  Ly  antigens 
characteristic of T cells. 
(b)  Replacement of Thymus  by Leukemia  Cells.  This  is  excluded  by the 
failure of thymocytes from 6-mo-old donors to produce leukemia after transplan- 
tation to young recipients. 
(c)  Preleukemic  Changes  in  the  Thymic  Cell Population  at High Risk  for 
Leukemia Transformation.  Current  evidence favors this possibility.  Surface 
markers and physical characteristics indicate that cells obtained from 2-mo and 
6-mo-old AKR thymus belong to the same lineage and represent the predomi- 
nant cell population,  cortical lymphocytes. Immunofluorescence on sections of 
thymus has localized the increase of MuLV-related antigens in 6-mo-old AKR 
mice to the thymic cortex.  The  thymic cortex is also the predominant  site of 
leukemia development in AKR mice. Thus, the cell population that is undergo- 
ing the age-dependent change in surface phenotype also appears to be the one 
that is at highest risk for leukemia transformation. 
Lymphoid cells in the thymic cortex are known to be derived from precursor KAWASHIMA,  IKEDA,  STOCKERT,  TAKAHASHI,  AND  OLD 
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FIG.  11.  Quantitative differences expressed as an absorption index in the amount of Ly- 
2.1  antigen  on thymocytes from AKR and  B6-Ly-2.1  mice of various ages and  on AKR 
thymic leukemia cells. Each symbol represents  results obtained  with cells from a  single 
donor. Reference cells for calculating absorption index; B6-Ly-2.1 thymocytes from 2-mo-old 
donors. 
cells that originate in the bone marrow (40). Under the influence of the thymic 
environment (presumably via  a  humoral factor produced by thymic stromal 
cells),  the immigrant cells engage in intense mitotic activity and undergo the 
phenotypic changes (Gix-,  TL-,  Ly-, Thy-1- --* Glx +,  TL  +,  Ly  +,  Thy-1  +) that 
characterize thymic lymphocytes. With regard to the modified expression of 
MuLV-related antigens and alloantigens on preleukemic thymocytes, it may be 
asked whether this reflects age-dependent changes in bone marrow precursor 
cells  or  in  cells  of the  thymic stroma.  Experiments with  thymic grafts  or 
involving radiation chimeras reconstituted with bone marrow from 2-mo or 6- 
mo-old AKR donors provide ways to approach this question. 
Previous studies have not found significantly higher MuLV titers in thymus 
of 6-mo-old AKR mice as compared to younger mice (9). This is surprising in 
view of the age-associated increase in MuLV-related antigens on AKR thymo- 
cytes.  In  collaboration with  Doctors J.  W.  Hartley and  W.  P.  Rowe of the 
National Institutes of Health, we have recently re-examined the issue of virus 
production by AKR thymus in relation to age. In accord with previous studies 
(9), the amount of mouse-tropic MuLV in 2-mo and 6-mo-old AKR thymus was 
not consistently different. Titers of xenotropic virus (as measured by fluorescent 
antigen induction in mink lung cells) were far higher in 6-mo-old AKR thymus 206  CELL  SURFACE  ANTIGENS  OF  PRELEUKEMIC  AKR  THYMOCYTES 
and correlated with amplified expression of MuLV-related antigens. 
In the study of the two naturally occurring oncogenic viruses of the mouse, 
mammary tumor viruses and MuLV, considerable advances have been made in 
our understanding of the factors that control susceptibility or resistance to these 
viruses and to the tumors they induce. Much has been learned about the genetic 
factors that determine virus production and dissemination, about immunologi- 
cal  restraints  on  tumor development and  growth,  and  about  the  hormonal 
influences that are involved in target cell susceptibility to viral transformation. 
Cancer development is also markedly age dependent, the incidence of mammary 
tumors and leukemia increasing with age. How this influence of age on cancer 
susceptibility is mediated remains unknown and is most probably part of the 
broader issue of age-related changes in the genetic control of differentiation. 
Further  analysis of the  defined changes  in  preleukemic  AKR thymus may 
provide fresh insights to an understanding of this problem. 
Summary 
Thymocytes  from preleukemic AKR mice aged 5-6 mo have an altered pattern 
of cell surface antigens. The expression of four MuLV-related antigens on the 
cell surface (G~×, GCSA, gp70, p30) is markedly increased in comparison to 2-mo- 
old AKR mice and approximates the heightened levels of these antigens found 
on thymic leukemia cells. H-2 and Thy-1 alloantigens also show characteristic 
modifications in relation to age and leukemia development. In contrast to the 
high Thy-1/low H-2 levels on 2-mo-old AKR thymocytes, thymocytes  from 6-too- 
old mice  and  thymic leukemia cells frequently show  a  low Thy-1/high H-2 
surface phenotype. As thymocytes from mouse strains with a  low incidence of 
leukemia do not show these changes, they appear to represent a  stage in the 
conversion of normal cells to leukemia cells. 
We thank  Dr.  E.  A.  Boyse for valuable discussions, Dr.  T.  Yoshiki for advice concerning 
membrane immunofluorescence,  and Dr. T. Kitahara for performing  the Cytograf  analyses. 
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